Defining successful treatment of neurogenic orthostatic hypotension with droxidopa in a patient with multiple system atrophy
Open Access
- 19 June 2017
- journal article
- case vignette
- Published by Springer Nature in Clinical Autonomic Research
- Vol. 27 (S1) , 21-23
Abstract
No abstract availableKeywords
Funding Information
- Lundbeck
This publication has 6 references indexed in Scilit:
- Clinical benefit of midodrine hydrochloride in symptomatic orthostatic hypotension: a phase 4, double-blind, placebo-controlled, randomized, tilt-table studyClinical Autonomic Research, 2016
- Meta-analysis of the safety and efficacy of droxidopa for neurogenic orthostatic hypotensionClinical Autonomic Research, 2016
- Supine hypertension in Parkinson’s disease and multiple system atrophyClinical Autonomic Research, 2016
- Droxidopa in neurogenic orthostatic hypotensionExpert Review of Cardiovascular Therapy, 2015
- Pyridostigmine for treatment of neurogenic orthostatic hypertensionClinical Autonomic Research, 2005
- The effect of desmopressin on nocturnal polyuria, overnight weight loss, and morning postural hypotension in patients with autonomic failure.BMJ, 1986